FdaApplication

NDA 216578

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASTELLAS PHARMA US INC
application_typeNDA
approval_date2023-05-12

Products (1)

ProductActive ingredientStrengthDosage form
VEOZAHFEZOLINETANT45MGTABLET;ORAL

1 product